Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rousselot

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Cancer|January 26, 2018
Dasatinib dose management for the treatment of chronic myeloid leukemiaMoshe Talpaz, Giuseppe Saglio, Ehab Atallah, et al.
Current Pharmaceutical Biotechnology|June 23, 2006
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemiasLaure Deville, Josette Hillion, Michel Lanotte, et al.
Blood Advances|July 3, 2020
Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remissionPhilippe Rousselot, Clémence Loiseau, Marc Delord, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2025
Elderly Acute Lymphoblastic Leukemia: Low-Dose Chemotherapy and Immunotherapy CombinationsPerrine Moyer, Aude-Marie Fourmont, Lucie Freiman, et al.
Leukemia Research|May 8, 2018
The rising prevalence of chronic myeloid leukemia in FranceMarc Delord, Stéphanie Foulon, Jean-Michel Cayuela, et al.
Current Hematologic Malignancy Reports|March 14, 2012
Curing chronic myeloid leukemiaDelphine Rea, Philippe Rousselot, Joelle Guilhot, et al.
Leukemia Research|July 30, 2018
Nivolumab to control molecular response in chronic myeloid leukemiaPhilippe Rousselot, Perrine Renard, Ariane de Buyer, et al.
The European Respiratory Journal|September 14, 2017
Bosutinib-related pneumonitisEtienne-Marie Jutant, Véronique Meignin, David Montani, et al.
British Journal of Haematology|March 22, 2003
Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylatePhilippe Rousselot, Jérome Larghero, Emmanuel Raffoux, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic LeukemiaElias J Jabbour, Philippe Rousselot, Nicola Gokbuget, et al.
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Cancer|January 26, 2018
Dasatinib dose management for the treatment of chronic myeloid leukemiaMoshe Talpaz, Giuseppe Saglio, Ehab Atallah, et al.
Current Pharmaceutical Biotechnology|June 23, 2006
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemiasLaure Deville, Josette Hillion, Michel Lanotte, et al.
Blood Advances|July 3, 2020
Late molecular recurrences in patients with chronic myeloid leukemia experiencing treatment-free remissionPhilippe Rousselot, Clémence Loiseau, Marc Delord, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 27, 2025
Elderly Acute Lymphoblastic Leukemia: Low-Dose Chemotherapy and Immunotherapy CombinationsPerrine Moyer, Aude-Marie Fourmont, Lucie Freiman, et al.
Leukemia Research|May 8, 2018
The rising prevalence of chronic myeloid leukemia in FranceMarc Delord, Stéphanie Foulon, Jean-Michel Cayuela, et al.
Current Hematologic Malignancy Reports|March 14, 2012
Curing chronic myeloid leukemiaDelphine Rea, Philippe Rousselot, Joelle Guilhot, et al.
Leukemia Research|July 30, 2018
Nivolumab to control molecular response in chronic myeloid leukemiaPhilippe Rousselot, Perrine Renard, Ariane de Buyer, et al.
The European Respiratory Journal|September 14, 2017
Bosutinib-related pneumonitisEtienne-Marie Jutant, Véronique Meignin, David Montani, et al.
British Journal of Haematology|March 22, 2003
Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylatePhilippe Rousselot, Jérome Larghero, Emmanuel Raffoux, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic LeukemiaElias J Jabbour, Philippe Rousselot, Nicola Gokbuget, et al.
Pageof 20